ACT-Accelerator launches six month plan as world transitions to long-term COVID-19 control
ACT-Accelerator launches six month plan as world transitions to long-term COVID-19 control - The Maravi Post
Source: maravipost.com
Diagnostics Pillar News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Diagnostics Pillar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Diagnostics Pillar Today - Breaking & Trending Today
The Global Fund Signs Agreement with Pfizer to Expand Access to PAXLOVID™ Antiviral
The Global Fund to Fight AIDS, TB and Malaria has signed an agreement with Pfizer for the procurement of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™
Source: theglobalfund.org
Global Fund Signs Letter of Intent with Pfizer for Oral COVID-19 Treatment
The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023.
Source: theglobalfund.org
Global Fund, United States and Unitaid Launch "Test-and-Treat" Programs at Second Global COVID-⁠19 Summit - News - The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund, the United States and Unitaid, together with FIND and other ACT-Accelerator partners, are launching over US$120 million in support to countries for test-and-treat programs to prevent hospitalizations and deaths from COVID-19 for those most at risk in low- and middle-income countries
Source: theglobalfund.org
COVID Testing Equity: A Reflection Based on 1.5 Years in the ACT-Accelerator
In access to testing, we continue to see this lack of decisive leadership in all spheres. Something must be done to expedite the procedures to enable deployment of community-based and self-tests now. We stand as co-actors in gross inequity. And we will stand for it no further.
Source: plos.org